Background
The concept of inferior vena cava (IVC) interruption to prevent pulmonary embolism is decades old and appears fiercely embedded in the clinical algorithms of many practitioners from diverse specialties. Such practice appears inconsistent with available data which suggest that IVC filters do not confer significant benefit for the vast majority of patients. On the contrary, in many cases IVC filters expose the patient to greater device-related risk. Logically, the absence of significant benefit and the presence of significant harm related to IVC filter implantation should reduce implantation rates. Sadly, IVC filters are still being widely implanted and, in fact, new devices are actually coming to market. As a result, clinicians will continue to be confronted with retained IVC filters and all the clinical and technical challenges related to retrieving them. In this 'Great Debate in Vascular Medicine' we review whether IVC filters should be routinely retrieved as part of standard clinical practice. Dr Weinberg: Many IVC filters can stay in; more careful selection for retrieval is needed IVC filter use is prevalent in the United States, 1 though often not justified based on clinical indications. 2 Furthermore, IVC filters do not confer any reliable clinical benefit to patients except in select instances. 3, 4 In fact, quite the opposite is true. These devices are frequently associated with complications at all phases of the device 'lifecycle': from implantation through to the time they remain in the body and during retrieval. 5 Although prompt retrieval would likely attenuate some of these harms, the literature indicates that actual IVC filter retrieval occurs infrequently and in a delayed fashion. Retrieval rates hover around 30% in published series. 5 As a result, the US Food and Drug Administration (FDA) has issued a call for IVC filters to be retrieved as soon as possible. 6 Surprisingly, none of the guidelines from relevant professional societies address the matter of retrieval, and rather focus on indications for insertion. 7 Despite consensus advocating retrieval, most IVC filters are still retained long-term. 8 This may result in two distinct sets of challenges. First, some of these retained filters may be associated with complications, such as thrombosis, penetration into adjacent organs, including the aorta, and migration, including to the heart and lungs. 7 This set of complications, though morbid, is simple from a management perspective. Simply put, patients presenting with IVC filter-related symptoms should have such symptoms addressed and should be considered for retrieval. That being said, while late retrieval is warranted in such cases, it may be complicated and sometimes technically impossible. When retrieval is clinically required but cannot be achieved with even aggressive techniques, the IVC filter can be crushed into the wall of the IVC, followed by percutaneous caval reconstruction. Such efforts require experience, persistence, and a skill set that is likely best left for highly specialized, interested centers. 9 The second set of challenges, most relevant to this debate, arises from chronically indwelling IVC filters without associated symptoms. While no consensus exists, chronically indwelling IVC filters may be defined as remaining in place beyond the primary indication (e.g. when anticoagulation has been initiated or is no longer required) and beyond the labeled recommended indwell time (which is variable between filters). In this context, clinicians should be alerted to the fact that radiographic abnormalities (e.g. tine penetration) do not necessarily equate with clinically meaningful complications. As the majority of IVC filter-related complications occur during the first 6 months after implantation, it is unclear how to handle the asymptomatic patient with an indwelling filter, and as complex retrieval may be associated with complications, many such filters should probably remain in place. 5 In sum, there is no argument against the fact that IVC filters should be retrieved quickly in all patients once the original indication for their use has passed. However, there are two specific instances in the context of chronic indwelling IVC filters that should actually be at the center of this debate. First, should chronically dwelling IVC filters that are not associated with complications be retrieved? And second, should IVC filters associated with stable radiographic (not clinical) complications be addressed with procedures? While these questions should represent outlier scenarios, they are unfortunately currently the norm. Thus, answering these questions appropriately is central to the topic of IVC filter management.
IVC filter retrieval is associated with complications. While uncommon, some can be severe, including embolization of a tine to the heart or lungs, IVC tear, penetration of a blood vessel or organ, or embolization of the entire IVC filter to the heart. 5 Any of these complications may result in patient harm, or at the least, in further need for invasive, often risky procedures. Practitioners should remember that nearly 80% of retained IVC filters are not associated with complications, while nearly 3% of retrieval attempts do result in a complication. 5 Thus, the vast majority of retained IVC filters should remain in place, and heroic retrieval attempts should be saved for only those patients who experience IVC filter-related symptoms.
Dr Bjarnason: All IVC filters should be retrieved
It was recognized early that patients with lower extremity deep venous thrombosis (DVT) had a high risk of developing pulmonary embolism with significant associated mortality. This was especially true before the era of anticoagulation. Recognizing that most pulmonary emboli originated from the lower extremities, extreme measures were taken to prevent migration of thrombi to the pulmonary arteries, which included variations of surgical interruption of the IVC. This obviously led to significant morbidity due to the invariable IVC occlusion (and obvious associated consequences of that) and the fact that this required an open surgery in patients who were often already very sick. 10, 11 The endovascular approach to IVC interruption came to light earlier than we may recognize with introduction of the detachable Hunter Balloon, a balloon inflated within the IVC. 12 Along with the development of the Hunter Balloon, the first IVC filter was introduced, the so-called 'MobinUddin umbrella', which was a silicon cone-shaped, perforated membrane delivered into the IVC and left in permanently. 13 There were complications associated with those devices that included high rates of IVC occlusion and migration.
Ultimately, along came the device that we most commonly associate with IVC interruption or filtration and often refer to in general terms when discussing the entity, namely the Kim-Ray-Greenfield filter or Greenfield filter. 14 This filter was initially delivered via a cutdown on the right internal jugular vein or femoral vein, but percutaneous placement techniques were later developed. 15 It became clear that IVC filtration was needed only temporarily in most cases and that it might be advantageous to be able to remove the device when the indication had passed. The Amplatz IVC filter was an example of an optionally retrievable filter, which was short-lived but a sign of the future as we now know it. 16 In 2002, the first clinical reports of removable or optional filters were introduced. One can argue that this has significantly changed the IVC filter landscape. 17 From the year 1997 onward, we have seen a significant rise in use of IVC filters. 18 This increase in usage has many roots, including: introduction of filter devices that were easier to place with a lower delivery profile, so the procedure became simple to perform and therefore to request; use of filters to protect the treating physician from litigation in case of a pulmonary embolism; and, not least, the option to remove the device when no longer needed. With this increased usage came the recognition that the devices were not without long-term risks. The risks were mainly migration, metal fatigue and fractures, thrombosis of the IVC, and extension into surrounding organs, such as the aorta, gastrointestinal tract, and spine, among others, with associated symptoms in some cases. 19 At the same time, it became painfully obvious that the indications for the use of IVC filters were poorly supported, as pointed out by a few randomized studies that indicated no survival benefit but possible significant long-term complications of IVC filter usage. 20, 21 It is quite possible that we have exceeded the reasonable indications for placement of IVC filters. This is probably most obvious in the case of the prophylactic use of IVC filters before certain surgical procedures and in patients with severe trauma. Despite significant efforts in most centers, only a quarter of filters placed will eventually be removed. At our institution, only 36% of filters are removed [unpublished data]. This low retrieval rate has many explanations that include a very sick patient population, the reality that patients may live far away from where the filter was placed, and simply that filer retrieval may be perceived as the least important issue the patient is dealing with.
I have been asked to argue for filter removal in all cases. This is obviously not possible, as many patients may have a permanent indication for IVC filter presence. There may also be other reasons that filter removal is not reasonable given a patients' age, estimated life expectancy, and other factors that for good common sense trump aggressive removal procedures. IVC filters should be removed in the younger population with long life expectancy where there is no indication for long-term filter presence. On the other hand, there are complications associated with filter removal, and the risk of filter removal has to be weighed against the risk of keeping filters in place.
Finally, as mentioned by Dr Weinberg above, the US FDA has published a communication that states that 'implanting physicians and clinicians responsible for the ongoing care of patients with retrievable IVC filters consider removing the filter as soon as protection from pulmonary embolism is no longer needed'. 6 Education and firm adherence to established indications may be the best place to start to reverse the 'filter epidemic'.
Summary
Inferior vena cava filters are not innocuous. The first step in curbing IVC filter-related complications should be reducing the number of devices implanted. Achieving such a reduction is more difficult than it appears, as a complex set of factors drive IVC filter implantation, including local culture, reimbursement policy, and legal issues. The result is an extensive geographic variability in IVC filter use. Admittedly, there are some very specific scenarios where IVC filters may have benefit but have yet to be adequately studied. However, such scenarios are rare and are being called upon all too frequently to justify questionable implantation.
The second step to decrease the risk of IVC filter-related complications is the promotion of prompt retrieval. As soon as the indication for their use has passed, IVC filters should be retrieved. Achieving this requires a group of committed practitioners to incorporate system-based solutions into their clinical decision-making process. As the problem has been inadequately remedied by societal publications and committee statements, both of us authors support FDA and CMS (Centers for Medicare & Medicaid Services) involvement in this matter. Until that time and for the foreseeable future, patients with chronically retained filters will present not uncommonly and will need to be managed by experienced practitioners on a case-bycase basis. Conservative monitoring is often sufficient for such patients, whereas complex retrieval may be used sparingly in select cases.
